HUP0301137A3 - Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same - Google Patents

Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same

Info

Publication number
HUP0301137A3
HUP0301137A3 HU0301137A HUP0301137A HUP0301137A3 HU P0301137 A3 HUP0301137 A3 HU P0301137A3 HU 0301137 A HU0301137 A HU 0301137A HU P0301137 A HUP0301137 A HU P0301137A HU P0301137 A3 HUP0301137 A3 HU P0301137A3
Authority
HU
Hungary
Prior art keywords
preparation
treatment
pharmaceutical composition
composition containing
same
Prior art date
Application number
HU0301137A
Other languages
Hungarian (hu)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HUP0301137A2 publication Critical patent/HUP0301137A2/en
Publication of HUP0301137A3 publication Critical patent/HUP0301137A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HU0301137A 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same HUP0301137A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (2)

Publication Number Publication Date
HUP0301137A2 HUP0301137A2 (en) 2003-08-28
HUP0301137A3 true HUP0301137A3 (en) 2005-04-28

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301137A HUP0301137A3 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
OA12284A (en) 2003-11-10
KR20030007918A (en) 2003-01-23
PL360592A1 (en) 2004-09-20
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
CN1443186A (en) 2003-09-17
BG107357A (en) 2003-08-29
MXPA02012100A (en) 2003-04-25
HUP0301137A2 (en) 2003-08-28
EP1296980A1 (en) 2003-04-02
MA25753A1 (en) 2003-04-01
NO20025883D0 (en) 2002-12-06
IL153279A0 (en) 2003-07-06
AP2002002673A0 (en) 2002-12-31
CA2411065A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
WO2001094344A1 (en) 2001-12-13
BR0111536A (en) 2003-07-01
NO20025883L (en) 2003-02-03
GB0014006D0 (en) 2000-08-02
DZ3382A1 (en) 2001-12-13
SK17142002A3 (en) 2003-10-07
CZ20023966A3 (en) 2003-04-16
ZA200209954B (en) 2003-10-10

Similar Documents

Publication Publication Date Title
EG24124A (en) Pharmaceutical compositions for the treatment of type-II diabetes mellitus
IL158593A (en) Arylsulfonamide compounds, process for preparation thereof and pharmaceutical compositions for the treatment of obesity, type ii diabetes and cns-disorders
PL370818A1 (en) Dosage form for treatment of diabetes mellitus
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
HUP0101158A3 (en) Use of glycogen phosphorylase inhibitors for the preparation of pharmaceutical compositions for the prophylactic treatment of type 2 diabetes mellitus
HUP0400823A3 (en) Heterocyclic compounds for treating aging-related and diabetic vascular complications, their preparation and pharmaceutical compositions containing them
HUP0105313A3 (en) Potassium salt of (s)-omeprazole, process for its preparation and pharmaceutical composition containing the same and its use
HUP0400932A3 (en) Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
HUP0301315A3 (en) Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HUP0401160A3 (en) 2,4,5-trisubstituted thiazolyl derivatives having antiinflammatory activity, process for their preparation and pharmaceutical compositions containing them
HUP0303398A3 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same
AU2000276362A1 (en) Composition for the treatment of diabetes
PL398391A1 (en) Hydroxyalkylstarch and polypeptide conjugate, process for the preparation of that conjugate, the use thereof and the pharmaceutical composition containing the hydroxyalkylstarch and polypeptide conjugate
IL165012A0 (en) (S)-4-Amino-5-chloro-2-methoxy-N-Ä1-(-tetrahydrofurylcarbonyl)-4-piperidinylmethylÜ-4-piperidinylÜbenzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0401612A3 (en) Pharmaceutical composition suitable for treating diabetes
HUP0401325A3 (en) Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
HUP0301137A3 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
HUP0200865A3 (en) Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical compositions containing it
HUP0200785A3 (en) Thiazolidinedione derivative and its use as antidiabetic, process for its preparation and pharmaceutical composition containing it
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
GB2355189B (en) Herbal preparation for the treatment of diabetes mellitus
EP1556364A4 (en) Isothiazole derivatives, process for the preparation thereof, and pharmaceutical composition including the same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees